| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB11
|
ATP-binding cassette, sub-family B (MDR/TAP), member 11
|
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABCC3
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACADM
|
acyl-CoA dehydrogenase, C-4 to C-12 straight chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADAMTS18
|
ADAM metallopeptidase with thrombospondin type 1 motif, 18
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADTRP
|
androgen-dependent TFPI-regulating protein
|
|
AFF2
|
AF4/FMR2 family, member 2
|
|
AFP
|
alpha-fetoprotein
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AMELX
|
amelogenin, X-linked
|
|
AMELY
|
amelogenin, Y-linked
|
|
ANK1
|
ankyrin 1, erythrocytic
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
AQP1
|
aquaporin 1 (Colton blood group)
|
|
AR
|
androgen receptor
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB2
|
arrestin, beta 2
|
|
ASL
|
argininosuccinate lyase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP13A2
|
ATPase type 13A2
|
|
ATXN2
|
ataxin 2
|
|
AXIN2
|
axin 2
|
|
BANK1
|
B-cell scaffold protein with ankyrin repeats 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C3
|
complement component 3
|
|
CALHM1
|
calcium homeostasis modulator 1
|
|
CAPN10
|
calpain 10
|
|
CBR3
|
carbonyl reductase 3
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CDSN
|
corneodesmosin
|
|
CES1P1
|
carboxylesterase 1 pseudogene 1
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHGA
|
chromogranin A
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CILP2
|
cartilage intermediate layer protein 2
|
|
CLCNKB
|
chloride channel, voltage-sensitive Kb
|
|
CLN5
|
ceroid-lipofuscinosis, neuronal 5
|
|
CNGB1
|
cyclic nucleotide gated channel beta 1
|
|
COL6A4P1
|
collagen, type VI, alpha 4 pseudogene 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
CYP3A7
|
cytochrome P450, family 3, subfamily A, polypeptide 7
|
|
CYP7B1
|
cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCK
|
deoxycytidine kinase
|
|
DNASE1
|
deoxyribonuclease I
|
|
DNASE1L1
|
deoxyribonuclease I-like 1
|
|
DNASE1L2
|
deoxyribonuclease I-like 2
|
|
DNASE2
|
deoxyribonuclease II, lysosomal
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DPY19L2
|
dpy-19-like 2 (C. elegans)
|
|
DRD1
|
dopamine receptor D1
|
|
DRD4
|
dopamine receptor D4
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK4
|
eukaryotic translation initiation factor 2 alpha kinase 4
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELN
|
elastin
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPHA2
|
EPH receptor A2
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ESR1
|
estrogen receptor 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FAAH
|
fatty acid amide hydrolase
|
|
FABP2
|
fatty acid binding protein 2, intestinal
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FANCG
|
Fanconi anemia, complementation group G
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCRL3
|
Fc receptor-like 3
|
|
FEV
|
FEV (ETS oncogene family)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FKTN
|
fukutin
|
|
FLG
|
filaggrin
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXE1
|
forkhead box E1
|
|
FOXO3
|
forkhead box O3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FTO
|
fat mass and obesity associated
|
|
FUS
|
FUS RNA binding protein
|
|
G6PC2
|
glucose-6-phosphatase, catalytic, 2
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4
|
|
GABRB1
|
gamma-aminobutyric acid (GABA) A receptor, beta 1
|
|
GALNT2
|
polypeptide N-acetylgalactosaminyltransferase 2
|
|
GBA
|
glucosidase, beta, acid
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
|
GDF10
|
growth differentiation factor 10
|
|
GDF5
|
growth differentiation factor 5
|
|
GH1
|
growth hormone 1
|
|
GJA3
|
gap junction protein, alpha 3, 46kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GLO1
|
glyoxalase I
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GNAL
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HBB
|
hemoglobin, beta
|
|
HFE
|
hemochromatosis
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXA1
|
homeobox A1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA1B
|
heat shock 70kDa protein 1B
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGHE
|
immunoglobulin heavy constant epsilon
|
|
IL10
|
interleukin 10
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL23R
|
interleukin 23 receptor
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
IMPDH2
|
IMP (inosine 5'-monophosphate) dehydrogenase 2
|
|
IRF2
|
interferon regulatory factor 2
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF6
|
interferon regulatory factor 6
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
JAG1
|
jagged 1
|
|
KCNJ8
|
potassium channel, inwardly rectifying subfamily J, member 8
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KIF21A
|
kinesin family member 21A
|
|
KIR2DL5A
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
L2HGDH
|
L-2-hydroxyglutarate dehydrogenase
|
|
LAMB1
|
laminin, beta 1
|
|
LCT
|
lactase
|
|
LEP
|
leptin
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
LIPC
|
lipase, hepatic
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LPL
|
lipoprotein lipase
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAOA
|
monoamine oxidase A
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEFV
|
Mediterranean fever
|
|
MFSD2A
|
major facilitator superfamily domain containing 2A
|
|
MIA3
|
melanoma inhibitory activity family, member 3
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTNR1B
|
melatonin receptor 1B
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAN
|
neurocan
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NKX2-3
|
NK2 homeobox 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHS2
|
nephrosis 2, idiopathic, steroid-resistant (podocin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRG1
|
neuregulin 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRM1
|
opioid receptor, mu 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK16
|
Parkinson disease 16 (susceptibility)
|
|
PARK7
|
parkinson protein 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX6
|
paired box 6
|
|
PBX4
|
pre-B-cell leukemia homeobox 4
|
|
PCSK9
|
proprotein convertase subtilisin/kexin type 9
|
|
PDCD1
|
programmed cell death 1
|
|
PEAR1
|
platelet endothelial aggregation receptor 1
|
|
PEPD
|
peptidase D
|
|
PGR
|
progesterone receptor
|
|
PHACTR1
|
phosphatase and actin regulator 1
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
PORCN
|
porcupine homolog (Drosophila)
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRNP
|
prion protein
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
PSMB9
|
proteasome (prosome, macropain) subunit, beta type, 9
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PYGM
|
phosphorylase, glycogen, muscle
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RAB5B
|
RAB5B, member RAS oncogene family
|
|
RAD51
|
RAD51 recombinase
|
|
RAET1E
|
retinoic acid early transcript 1E
|
|
RAET1L
|
retinoic acid early transcript 1L
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic)
|
|
RP1
|
retinitis pigmentosa 1 (autosomal dominant)
|
|
SBDS
|
Shwachman-Bodian-Diamond syndrome
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SDC3
|
syndecan 3
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPA2
|
surfactant protein A2
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC29A3
|
solute carrier family 29 (equilibrative nucleoside transporter), member 3
|
|
SLC44A2
|
solute carrier family 44 (choline transporter), member 2
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO2B1
|
solute carrier organic anion transporter family, member 2B1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORCS1
|
sortilin-related VPS10 domain containing receptor 1
|
|
SPINK5
|
serine peptidase inhibitor, Kazal type 5
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A2
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2
|
|
SUMF1
|
sulfatase modifying factor 1
|
|
SUOX
|
sulfite oxidase
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFR2
|
transferrin receptor 2
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBS1
|
thrombospondin 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TMEM70
|
transmembrane protein 70
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TPH2
|
tryptophan hydroxylase 2
|
|
TPO
|
thyroid peroxidase
|
|
TRIT1
|
tRNA isopentenyltransferase 1
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TTN
|
titin
|
|
TTR
|
transthyretin
|
|
TYK2
|
tyrosine kinase 2
|
|
TYMS
|
thymidylate synthetase
|
|
UGT1A4
|
UDP glucuronosyltransferase 1 family, polypeptide A4
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
ULBP3
|
UL16 binding protein 3
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VWF
|
von Willebrand factor
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WNK4
|
WNK lysine deficient protein kinase 4
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YAP1
|
Yes-associated protein 1
|
|
ZFP36
|
ZFP36 ring finger protein
|
|
ZFP36L1
|
ZFP36 ring finger protein-like 1
|
|
ZFP36L2
|
ZFP36 ring finger protein-like 2
|
|
ZNF510
|
zinc finger protein 510
|
|
ZNF782
|
zinc finger protein 782
|
|
ZPR1
|
ZPR1 zinc finger
|